CELG
reuters.dev
http://www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F2585252&ei=knKaUrDjLa210AHc1AE&usg=AFQjCNHadSfHrF4T6uh_3GdJLyx1ynIwkw
Celgene Corporation Announces Offering Of Senior Unsecured Notes
Monday, 6 Aug 2012 09:02am EDT
Celgene Corporation announced its intention to offer, subject to market and other conditions, senior unsecured notes under a shelf registration statement on Form S-3 on file with the Securities and Exchange Commission. The interest rate, the maturity dates and other key terms of the offering are to be determined at the time of pricing. Celgene expects to use the net proceeds from the offering for general corporate purposes, which may include, without limitation, further development of Celgene’s clinical and pre-clinical programs, capital expenditures, general corporate development activities and meeting working capital needs. BofA Merrill Lynch, J.P. Morgan and Morgan Stanley are acting as joint book-running managers. 
